Author | David L. Rimm, MD, PhD | OncLive

Author | David L. Rimm, MD, PhD

Articles

Dr. David L. Rimm on the Continued Role for PD-L1 Testing in NSCLC

November 03, 2016

Video

David L. Rimm, MD, PhD, professor of pathology and of medicine, director of pathology tissue services, director of translational pathology, Yale Cancer Center, discusses the continued role for PD-L1 testing to predict response with checkpoint inhibitors in non­–small cell lung cancer (NSCLC).

Dr. Rimm on Biomarker Testing in Lung Cancer

October 19, 2016

Video

David L. Rimm, MD, PhD, professor of pathology and of medicine, director of pathology tissue services, director of translational pathology, Yale Cancer Center, discusses various options for biomarker testing in lung cancer.

x